Lanean...
Assessment of circulating tumor DNA in pediatric solid tumors: The promise of liquid biopsies
Circulating tumor DNA (ctDNA) can be detected in the blood and body fluids of patients using ultra-sensitive technologies which have the potential to improve cancer diagnosis, risk stratification, non-invasive tumor profiling, and tracking of treatment response and disease recurrence. As we begin to...
Gorde:
| Argitaratua izan da: | Pediatr Blood Cancer |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6550461/ https://ncbi.nlm.nih.gov/pubmed/30614191 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.27595 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|